Product & Marketing

Toku’s eye scan for kidney trouble on regulatory fast track in US

1 May 2024

Toku Eyes

The US Food and Drug Administration (FDA) has qualified for its Breakthrough Device Program an AI suite from Toku Inc. that is designed to detect chronic kidney disease (CKD) from the retinal scans of diabetics.

Already an Eyewear Intelligence subscriber? Sign in here.

barrier_image_OIC

Subscribe today

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Organisation-wide access across offices, people and devices

SUBSCRIBE TODAY

To continue reading this article register now.